Tick-borne encephalitis more common: number of hospitalized patients increased
3.12.2025 10:03:20 EET | HUS | Press release
The number of tick-borne encephalitis cases (TBE) has clearly increased from last year. The increase has been evident at HUS emergency departments, on neurology wards, as well as on intensive and intermediate care units. TBE has surpassed herpesvirus as a leading cause of severe encephalitis.

Last year, the total number of TBE cases diagnosed in Finland was 195, but by the end of November 2025, 227 cases have already been entered in the Finnish National Infectious Diseases Register.
In the HUS region, the number of TBE cases has increased from 91 in 2024 to 120 at the end of November 2025. TBE has been common in Western Uusimaa previously as well, but now the number of cases has increased in Helsinki especially. Some of the affected Helsinki residents may have contracted the infection elsewhere. All cases of TBE are annually reported to the National Infectious Diseases Register maintained by the Finnish Institute for Health and Welfare (THL).
Three out of four patients have incomplete vaccinations
The increase in the number of cases has been evident in the West Uusimaa wellbeing services county, and at HUS emergency departments in Lohja, Jorvi, and Meilahti hospitals. At worst, during the summer, a third of the patients admitted to Jorvi Hospital Neurology Ward had TBE. In the HUS region, 14% of TBE patients needed intensive or intermediate care. Some of the patients who received intensive care require long rehabilitation before they can be discharged.
Two percent of patients diagnosed with TBE died. The actual mortality is lower than this, as a significant number of minor TBE cases are never diagnosed. Of all patients with TBE, 69% had no vaccination, and 13% had received incomplete immunization or the immunization was no longer effective.
TBE more common than herpes
TBE has surpassed herpesvirus as a leading cause of severe encephalitis, at least during the summer. Herpesviruses remain a significant cause of encephalitis and are treated with antiviral medication. The occurrence of herpesviruses does not change with the seasons, whereas TBE occurs mainly in the summer and early fall.
The TBE virus is transmitted through tick bites already at an early stage of the bite. Only some of the infected have symptoms, and about 20–30% of those with symptoms develop actual encephalitis.
Get TBE vaccine now
There is a vaccination against TBE, and it prevents infections in about 90% of vaccinated people. The vaccine is free for people who live in certain risk areas.
“People who spend time in nature in the risk areas should now get the TBE vaccine for next summer. This could decrease the amount of TBE cases,” says Infectious Diseases Specialist Elisa Kortela from HUS Inflammation Center.
The immunization is complete after a series of three doses. Everyone will also need a booster three years later, after which the interval of boosters depends on the person's age.
The majority of tick bites remain unnoticed. When roaming in nature, check if the region is one of the tick-bite risk regions defined by THL, where the vaccines are especially recommended. These include Lohja, Kirkkonummi, Espoo, Sipoo, and parts of Helsinki. Ticks may also end up indoors in pets’ fur.
Keywords
Contacts
Elisa KortelaSpecialist, HUS Inflammation Center
Tel:050 427 1507elisa.kortela@hus.fiAuli Verkkoniemi-AholaChief Physician, HUS Neurocenter
Tel:050 427 0312auli.verkkoniemi-ahola@hus.fiAbout HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our more than 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Rauhallinen suhtautuminen tukee psyykkistä kestävyyttä - epävarmuus kuormittaa mieltä27.4.2026 09:05:00 EEST | Tiedote
Epävarmuutta aiheuttava ja poikkeuksellinen uutisointi Suomen turvallisuustilanteesta ja lähialueiden geopoliittisesta kehityksestä voivat kuormittaa mieltä, vaikka ne eivät koskettaisikaan suoraan omaa arkea. Lisääntynyt huoliajattelu, valppauden kohoaminen ja keskittymisen vaikeus ovat tavallisia ja inhimillisiä reaktioita tilanteissa, joissa tietoa on rajallisesti tai se muuttuu nopeasti. On myös yksilöllistä vaihtelua siinä, miten yhteiskunnallisessa keskustelussa keskiössä olevaan tietotulvaan reagoi.
Barncancervårdens resultat ligger på en utmärkt nivå i hela Finland24.4.2026 08:48:31 EEST | Pressmeddelande
Behandlingsresultaten för cancer hos barn i Finland ligger på nordisk nivå och är internationell sett mycket goda. Behandlingsresultaten för många cancersjukdomar hör till de bästa i världen. Sex av sju barn under 16 år som drabbats av cancer tillfrisknar.
Lasten syöpähoidon tulokset erinomaisella tasolla koko Suomessa24.4.2026 08:48:31 EEST | Tiedote
Lasten syöpien hoitotulokset ovat Suomessa pohjoismaisella tasolla ja kansainvälisesti vertailtuna erittäin hyviä. Monien syöpäsairauksien hoidon tulokset ovat maailman kärkitasoa. Syöpään sairastuneista alle 16-vuotiasta lapsista kuusi seitsemästä paranee.
Outcomes of childhood cancer treatment at an excellent level everywhere in Finland24.4.2026 08:48:31 EEST | Press release
Finland's treatment outcomes for childhood cancer are on par with other Nordic countries and rank very high in international comparison. For many cancers, the treatment outcomes are among the best in the world. Six in seven children diagnosed with cancer before age 16 recover.
Användningen av kontaktlinser syns som ett ökat antal hornhinneinflammationer vid HUS23.4.2026 12:23:44 EEST | Pressmeddelande
Allvarliga hornhinneinflammationer orsakade av kontaktlinser syns vid HUS jour och mottagningarna för ögonsjukdomar. Hornhinneinflammation, det vill säga keratit, kan i värsta fall förstöra synförmågan. En stor del av fallen skulle helt kunna förebyggas.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom